Antiviral response and induction of specific proteins in cells treated with immune T (type II) interferon analogous to that from viral interferon (type I)-treated cells.
D015088:2',5'-Oligoadenylate Synthetase; D000227:Adenine Nucleotides / Q000096:biosynthesis; D000818:Animals; D002478:Cells, Cultured; D007372:Interferons / Q000096:biosynthesis / Q000494:pharmacology*; D007739:L Cells / Q000187:drug effects* / Q000378:metabolism; D008574:Mengovirus / Q000187:drug effects* / Q000254:growth & development; D051379:Mice; D008970:Molecular Weight; D009522:Newcastle disease virus; D009843:Oligoribonucleotides / Q000096:biosynthesis; D010452:Peptide Biosynthesis; D010835:Phytohemagglutinins / Q000494:pharmacology; D011118:Polynucleotide Ligases / Q000096:biosynthesis*; D014176:Protein Biosynthesis; D011494:Protein Kinases / Q000096:biosynthesis*; D013154:Spleen
D000227:Adenine Nucleotides; D009843:Oligoribonucleotides; D010835:Phytohemagglutinins; D007372:Interferons; D011494:Protein Kinases; D015088:2',5'-Oligoadenylate Synthetase; D011118:Polynucleotide Ligases